Pharma Stocks
-
BofA Securities Lifts Amylyx Pharmaceuticals Inc. (AMLX) Price Target Amid Bolstered Balance Sheet
Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential. On October 3,…
Read More » -
Examining Bristol-Myers Squibb Shares After Steep 22.8% Drop and Clinical Trial Updates
If you’re eyeing Bristol-Myers Squibb and wondering whether now is the time to act, you’re not alone. There’s been plenty…
Read More » -
Is Progress on Cancer Drug Candidates and Big Pharma Partnerships Altering the Investment Case for ORIC Pharmaceuticals (ORIC)?
ORIC Pharmaceuticals has attracted attention after advancing its cancer drug candidates, ORIC-114 and ORIC-944, into Phase 1b studies and announcing…
Read More » -
Assessing Ascletis Pharma (SEHK:1672) Valuation After Strong Share Price Surge
Ascletis Pharma (SEHK:1672) recently closed at HK$9.12, catching the attention of investors who are gauging its performance over the month…
Read More » -
ANI Pharmaceuticals (ANIP): What Recent Momentum Means for Its Valuation
ANI Pharmaceuticals (ANIP) shares have been on the move lately, drawing attention from investors examining the company’s long-term performance and…
Read More » -
EMA Committee’s Positive Opinion on PYRUKYND Might Change The Case For Investing In Agios Pharmaceuticals (AGIO)
Agios Pharmaceuticals recently announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion…
Read More » -
Syndax Pharmaceuticals Shares Halted, Pending Material News Release
Market Closed – Nasdaq 04:00:00 2025-10-24 pm EDT After hours 06:14:08 pm 13.53 USD -7.83% 13.35 -1.33% Published on 10/24/2025…
Read More » -
Best Momentum Stocks to Buy for Oct. 24
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Oct. 24: Avino Silver…
Read More » -
Aurobindo Pharma Sees 15.86% Surge in Open Interest Amid Increased Trading Activity
Aurobindo Pharma Ltd. has seen a notable rise in open interest, reaching 67,490, alongside a trading volume of 33,423. The…
Read More » -
Is Arrowhead Pharmaceuticals Fairly Priced After Its 90% Year to Date Share Surge in 2025?
Trying to decide whether to buy, hold, or sell Arrowhead Pharmaceuticals? You’re not alone. The stock’s journey lately has caught…
Read More »